Saliva is a non-invasive, readily accessible biofluid containing electrolytes, enzymes, proteins, nucleic acids, metabolites, extracellular vesicles, cells, and microorganisms, with growing value in clinical diagnostics and biomedical research. This chapter provides a practical, evidence-based synthesis of laboratory methods for salivary analysis and links platform selection to intended use, specimen type, biological target, expected abundance, matrix behavior, and required analytical performance. Established approaches reviewed include biochemical and enzymatic assays, immunoassays, nucleic acid amplification, proteomics, metabolomics, microbial culture, and sequencing-based microbiome analysis. Emerging technologies, including microfluidic systems, biosensors, CRISPR-based diagnostics, wearable devices, multi-omics integration, and artificial intelligence, are also critically considered. Particular attention is given to pre-analytical variables, including collection method, sampling time, stimulation, diet, oral hygiene, medication use, processing, transport, and storage, as well as to low analyte concentrations, viscosity, oral contamination, matrix interference, and biological variability. The chapter evaluates representative applications in infectious diseases, oral and systemic disorders, endocrine monitoring, toxicology, neonatal care, and population-specific settings. Current evidence is strongest for selected infectious-disease workflows, oral-disease applications, and longitudinal hormone measurement, whereas many systemic biomarker panels, prediction models, and wearable platforms remain developmental. Successful translation requires saliva-specific analytical validation, appropriate calibration and quality control, comparison with accepted reference methods, predefined clinical thresholds, independent external validation, transparent reporting, and international interlaboratory assessment. When these requirements are met, saliva can complement established specimens and enable scalable, repeated, decentralized, and patient-friendly testing across research, screening, diagnosis, prognosis, and treatment monitoring contexts. The emphasis throughout is on fit-for-purpose workflows and cautious interpretation of clinical utility.